| Higher-dose statins raise risk for osteoporosis |
| CVS halts all sales of Zantac, store-brand ranitidine |
| 3-year COAPT results bolster MitraClip’s success |
| Frequent, persistent hot flashes predict later CVD events |
| FDA greenlights early feasibility study for less-invasive TMVR system |
| Bootleg cannabis pens found to contain vitamin E, pesticides |
| Shorter-duration DAPT looks favorable for patients at a high risk of bleeding after PCI |
| Robocath completes 1st in-human robotic angioplasties |
| ABSORB III: 5-year results offer renewed hope for bioresorbable stents |
| 1 in 4 MI survivors confused about the role of aspirin in secondary prevention |
| Idaho electrophysiologist 1st woman to complete 1,000 robotic catheter ablations |
| PCI mortality rates poor indicators of hospital quality |
| Communication training improves end-of-life discussions between HF patients, physicians |
| New Jersey cardiologist goes to trial for sexual misconduct |
| Europe’s 1st digital health CV conference kicks off in October |
| Machine learning cuts cardiac MRI analysis from minutes to seconds |
| Exposure to secondhand smoke in childhood increases lifetime risk of AFib |
| FDA expands losartan recall—again |
| Therapeutic shoe improves stroke survivors’ gait, symmetry |
| Treating hypertension could slow cognitive decline |
| Cardiac amyloidosis increasingly common in US |
| UNC Children’s cleared to resume complex heart surgeries |
| At-home BP tests more accurate for black patients |
| High-dose radiation improves survival in tachycardia patients |
| Failed TAVR more common in women, those with PAD |
| ACC takes steps toward equal pay, opportunity with new guidance |
| Zantac pulled from global markets amid investigation |
| ‘Alarming’ number of heart infections can be traced back to opioid epidemic |
| Surgical bailout during TAVR linked to poor outcomes |
| More female trainees, but still not enough women in cardiology |
| NLA endorses icosapent ethyl for use in high-risk patients |
| Study finds aspirin beneficial for some without established CVD |
| CIED infection rates on the rise |
| Dapagliflozin fast-tracked again—this time to treat heart failure |
| Focused ultrasound helps screen for heart disease in cats |
| ASNC releases multisocietal amyloidosis imaging guidelines |
| FDA warns of probable carcinogens in Zantac, other heartburn drugs |
| Apple launches a new heart study |
| Study adds to pool of evidence that paclitaxel-coated devices are safe |
| Men with erectile dysfunction prone to heart disease, stroke |
| Quicker diagnosis protocol for suspected ACS fails to improve outcomes |
| Napping twice a week lowers risk of CVD |
| Neural network IDs congestive heart failure with 100% accuracy |
| Fluoroquinolone use predicts aortic, mitral regurgitation |
| On Revolution |
| Tracks & Training at TCT.19: The 2019 Transcatheter Cardiovascular Therapeutics scientific symposium will convene Sept. 25-29 in San Francisco. |
| Chicago company 3D-bioprints mini human heart |
| Almost 2/3 of medical students have higher-than-normal blood pressure |
| Pocket-sized: Pointers for Using (& Not Using) Handheld Point-of-Care Echocardiography |
| Algorithmic Potential: Leveraging Deep Learning to Improve Arrhythmia Identification & Classification |
| ‘We’re moving in the wrong direction’: Why younger people are having more heart attacks |
| Tackling the Undertreatment of Aortic Stenosis in the U.S. |
| Transcarotid Access: The Future of Non-femoral TAVR? |
| As Surgery Gives Way to Transcatheter Procedures, Is the Cardiology Cash Cow in Jeopardy? |
| FDA Expands Indication for TAVR to Low-risk Patients |
| FDA slams Juul for marketing e-cigarettes as ‘totally safe’ |
| Who Shouldn’t Get TAVR? Lower-risk TAVR Raises New Challenges Around Assessing Patient Eligibility |
| Hub & Spoke: Improving Cardiogenic Shock Outcomes at WellStar |
| Native Hawaiians successfully lower BP with hula program |
| 18 years later: What 9/11 meant for firefighters’ heart health |
| Gut bacteria helps researchers ID new types of hypertension |
| 30% of ICD patients drive illegally after procedure |
| Vitamin E could be the culprit behind vaping-related lung disease |
| Motivational texting helps those with diabetes, CHD control glucose |
| Orchestra BioMed earns CE mark for BackBeat cardiac neuromodulation therapy |
| Educational status predicts death, CV events |
| Malaria tied to 30% increased risk of HF |
| Photoplethysmography promising as AFib screening tool |
| French startup Robocath raises $5.5M for CV robotics platform |
| Men who live alone struggle with taking warfarin |
| Cardiovascular RCTs are getting more practical—but slowly |
| Biodegradable polymer-coated DES safe, effective at 3 years |
| Cancer replaces CVD as no. 1 killer in high-income countries |
| Yearly flu shot decreases risk of death for hypertensive patients |
| Complete revascularization more beneficial than culprit-only PCI after STEMI |
